Patients with progressive degenerative eyesight, have been waiting for a cure. For years retinal replacement has been nothing but a wish. But with protoKinetix (PKTX) lives can be changed. PKTX is a biomedical research and development company leading the way to find cell survival solutions for 20 years.
PKTX uses AAGP® (Anti-Aging Glycopeptide), to keep healthy cells alive longer. The same properties that help animals survive in artic temperatures, makes it possible for AAGP® to impact regenerative medicine.
What is retinal replacement?
Retinal replacement is a surgery that transplants and grafts an eye’s retina, using induced self-renewing, or pluripotent stem cells.
Who is retinal replacement for?
Retinal replacement surgery is for anyone experiencing untreatable blinded, age-related retinal degeneration. These could be caused by birth defects, physical injury, tumors, inflammation, or glaucoma.
How successful is retinal replacement?
While PKTX is still in the clinal-stages, as a biomedical company. But after extensive testing and research, PKTX has restored vision in blind test subjects.
Additional applications for AAGP® (Anti-Aging Glycopeptide)
An estimated 12 million Americans live with vision impairment, according to the Centers for Disease Control and Prevention. PKTX can use AAGP® to help restore their eyesight and everyday life as they once knew it.
It also has the potential to cure chronic dry eye disease, diabetic retinopathy, macular degeneration, Sjorgren’s Syndrome and Uveitis.
PKTX is currently testing AAGP® to cure effects from inflammation, UV radiation and burn recovery. Potential applications can be used in anti-aging skincare and treat sunburned lips with an AAGP®-infused lip balm.
According to the Health Resources & Services Administration, more than 100,000 people in the United States are waiting on an organ transplant. Each day, 80 people receive them. PKTX can have a life changing impact on thousands of people by utilizing AAGP®’s regenerative cell technology, around the world.
AAGP® is used in biomanufacturing of cells to produce blood stem cells, insulin producing cells or immunotherapy cells to fight cancer. This could be the MedTech breakthrough we have all been waiting for.
Invest in the future of regenerative medicine.
Change lives through cell survival. Invest in PKTX.